After a five-decade-long career, Juergen Hasenkopf, 73, says he can continue to travel around the world for 10 more years
Nearly 30 generic drugs manufacturers signed an agreement to produce low-cost versions of Merck & Co's Covid-19 pill molnupiravir, the UN-backed Medicines Patent Pool (MPP) said on Thursday.
The agreement, negotiated by the MPP with Merck, allows 27 generic drugmakers from India, China and other countries in Africa, Asia and the Middle East to produce ingredients and the finished drug.
The MPP said that deal stipulates that the pill will be distributed to 105 less-developed nations. The developers of molnupiravir, which alongside Merck are US firm Ridgeback Biotherapeutics and Emory University, will not receive royalties for the sale of its low-cost version produced by generic drugmakers.
ALSO READ:
"This is a critical step towards ensuring global access to an urgently needed Covid-19 treatment and we are confident that, as manufacturers are working closely with regulatory authorities, the anticipated treatments will be rapidly available," said MPP Executive Director Charles Gore.
After a five-decade-long career, Juergen Hasenkopf, 73, says he can continue to travel around the world for 10 more years
Through her unique ‘Life Director’ method, theatre director, author and life coach Nadine Chammas teaches people how to craft a script, be a professional actor and direct their own lives
Prompted and supported by his wife, Shaista Naz, how former electronic engineer Masroor Syed started and established a business in 1995 that now includes his three sons
She learnt her toughest financial lessons amidst her mother’s battle with cancer
The pandemic saw a significant rise in number of cases of anxiety
The art of glow... and glory
March being the World Endometriosis Awareness Month, we attempt to decode the not-so-widely understood condition that condemns its sufferers to a life of unbearable pain
UAE resident shares why she chose the 2020 Nissan Altima to be her road companion